Consolidated Balance Sheets - USD ($) $ in Millions	Aug. 31, 2023	Feb. 28, 2023
Current
Cash and cash equivalents (note 2)	$ 415	$ 295
Short-term Investments	41	131
Accounts Receivable, after Allowance for Credit Loss, Current	127	120
Other receivables (note 3)	8	12
Income taxes receivable	5	3
Other current assets (note 3)	49	182
Assets, Current, Total	645	743
Restricted cash and cash equivalents (note 2)	28	27
Long-term investments (note 2)	35	34
Other long-term assets (note 3)	62	8
Operating Lease, Right-of-Use Asset	43	44
Property, plant and equipment, net (note 3)	22	25
Goodwill (note 3)	597	595
Intangible assets, net (note 3)	181	203
Assets	1,613	1,679
Current
Accounts payable	18	24
Accrued liabilities (note 3)	117	143
Income taxes payable (note 4)	21	20
Debentures (note 5)	383	367
Deferred revenue, current (note 10)	174	175
Total current liabilities	713	729
Deferred revenue, non-current (note 10)	21	40
Operating lease liabilities	49	52
Other long-term liabilities	1	1
Total liabilities	784	822
Capital stock and additional paid-in capital
Preferred shares: authorized unlimited number of non-voting, cumulative, redeemable and retractable	0	0
Common shares: authorized unlimited number of non-voting, redeemable, retractable Class A common shares and unlimited number of voting common shares Issued - 583,684,455 voting common shares (February 28, 2023 - 582,157,203)	2,931	2,909
Deficit	(2,081)	(2,028)
Accumulated other comprehensive loss (note 8)	(21)	(24)
Total shareholders' equity	829	857
Total liabilities and shareholders' equity	$ 1,613	$ 1,679
Common issued (in shares)	583,684,455	582,157,203
Common outstanding (in shares)	583,684,455	582,157,203